Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Biomarker Discovery
1.2.3 Blood Sample Testig
1.2.4 Others
1.3 Market by Application
1.3.1 Global PCR and NGS-Based Molecular Diagnostics Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals
1.3.3 Academics/Research Institutions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global PCR and NGS-Based Molecular Diagnostics Market Perspective (2018-2033)
2.2 PCR and NGS-Based Molecular Diagnostics Growth Trends by Region
2.2.1 Global PCR and NGS-Based Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 PCR and NGS-Based Molecular Diagnostics Historic Market Size by Region (2018-2023)
2.2.3 PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Region (2024-2033)
2.3 PCR and NGS-Based Molecular Diagnostics Market Dynamics
2.3.1 PCR and NGS-Based Molecular Diagnostics Industry Trends
2.3.2 PCR and NGS-Based Molecular Diagnostics Market Drivers
2.3.3 PCR and NGS-Based Molecular Diagnostics Market Challenges
2.3.4 PCR and NGS-Based Molecular Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top PCR and NGS-Based Molecular Diagnostics Players by Revenue
3.1.1 Global Top PCR and NGS-Based Molecular Diagnostics Players by Revenue (2018-2023)
3.1.2 Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Players (2018-2023)
3.2 Global PCR and NGS-Based Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by PCR and NGS-Based Molecular Diagnostics Revenue
3.4 Global PCR and NGS-Based Molecular Diagnostics Market Concentration Ratio
3.4.1 Global PCR and NGS-Based Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by PCR and NGS-Based Molecular Diagnostics Revenue in 2022
3.5 PCR and NGS-Based Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players PCR and NGS-Based Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into PCR and NGS-Based Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 PCR and NGS-Based Molecular Diagnostics Breakdown Data by Type
4.1 Global PCR and NGS-Based Molecular Diagnostics Historic Market Size by Type (2018-2023)
4.2 Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Type (2024-2033)
5 PCR and NGS-Based Molecular Diagnostics Breakdown Data by Application
5.1 Global PCR and NGS-Based Molecular Diagnostics Historic Market Size by Application (2018-2023)
5.2 Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America PCR and NGS-Based Molecular Diagnostics Market Size (2018-2033)
6.2 North America PCR and NGS-Based Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023)
6.4 North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe PCR and NGS-Based Molecular Diagnostics Market Size (2018-2033)
7.2 Europe PCR and NGS-Based Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023)
7.4 Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size (2018-2033)
8.2 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Region (2018-2023)
8.4 Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America PCR and NGS-Based Molecular Diagnostics Market Size (2018-2033)
9.2 Latin America PCR and NGS-Based Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023)
9.4 Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size (2018-2033)
10.2 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023)
10.4 Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermofisher
11.1.1 Thermofisher Company Detail
11.1.2 Thermofisher Business Overview
11.1.3 Thermofisher PCR and NGS-Based Molecular Diagnostics Introduction
11.1.4 Thermofisher Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.1.5 Thermofisher Recent Development
11.2 Illumine
11.2.1 Illumine Company Detail
11.2.2 Illumine Business Overview
11.2.3 Illumine PCR and NGS-Based Molecular Diagnostics Introduction
11.2.4 Illumine Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.2.5 Illumine Recent Development
11.3 Paragon Genomics
11.3.1 Paragon Genomics Company Detail
11.3.2 Paragon Genomics Business Overview
11.3.3 Paragon Genomics PCR and NGS-Based Molecular Diagnostics Introduction
11.3.4 Paragon Genomics Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.3.5 Paragon Genomics Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche PCR and NGS-Based Molecular Diagnostics Introduction
11.4.4 Roche Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.4.5 Roche Recent Development
11.5 Qiagen
11.5.1 Qiagen Company Detail
11.5.2 Qiagen Business Overview
11.5.3 Qiagen PCR and NGS-Based Molecular Diagnostics Introduction
11.5.4 Qiagen Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.5.5 Qiagen Recent Development
11.6 Bioo Scientific
11.6.1 Bioo Scientific Company Detail
11.6.2 Bioo Scientific Business Overview
11.6.3 Bioo Scientific PCR and NGS-Based Molecular Diagnostics Introduction
11.6.4 Bioo Scientific Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.6.5 Bioo Scientific Recent Development
11.7 Agilent
11.7.1 Agilent Company Detail
11.7.2 Agilent Business Overview
11.7.3 Agilent PCR and NGS-Based Molecular Diagnostics Introduction
11.7.4 Agilent Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.7.5 Agilent Recent Development
11.8 Pillar Biosciences
11.8.1 Pillar Biosciences Company Detail
11.8.2 Pillar Biosciences Business Overview
11.8.3 Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Introduction
11.8.4 Pillar Biosciences Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.8.5 Pillar Biosciences Recent Development
11.9 LC-Bio Technologies (Hangzhou) CO. LTD.
11.9.1 LC-Bio Technologies (Hangzhou) CO. LTD. Company Detail
11.9.2 LC-Bio Technologies (Hangzhou) CO. LTD. Business Overview
11.9.3 LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Introduction
11.9.4 LC-Bio Technologies (Hangzhou) CO. LTD. Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.9.5 LC-Bio Technologies (Hangzhou) CO. LTD. Recent Development
11.10 iGen Technologies
11.10.1 iGen Technologies Company Detail
11.10.2 iGen Technologies Business Overview
11.10.3 iGen Technologies PCR and NGS-Based Molecular Diagnostics Introduction
11.10.4 iGen Technologies Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.10.5 iGen Technologies Recent Development
11.11 Burning Rock
11.11.1 Burning Rock Company Detail
11.11.2 Burning Rock Business Overview
11.11.3 Burning Rock PCR and NGS-Based Molecular Diagnostics Introduction
11.11.4 Burning Rock Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
11.11.5 Burning Rock Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Biomarker Discovery
Table 3. Key Players of Blood Sample Testig
Table 4. Key Players of Others
Table 5. Global PCR and NGS-Based Molecular Diagnostics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global PCR and NGS-Based Molecular Diagnostics Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global PCR and NGS-Based Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global PCR and NGS-Based Molecular Diagnostics Market Share by Region (2018-2023)
Table 9. Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global PCR and NGS-Based Molecular Diagnostics Market Share by Region (2024-2033)
Table 11. PCR and NGS-Based Molecular Diagnostics Market Trends
Table 12. PCR and NGS-Based Molecular Diagnostics Market Drivers
Table 13. PCR and NGS-Based Molecular Diagnostics Market Challenges
Table 14. PCR and NGS-Based Molecular Diagnostics Market Restraints
Table 15. Global PCR and NGS-Based Molecular Diagnostics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global PCR and NGS-Based Molecular Diagnostics Market Share by Players (2018-2023)
Table 17. Global Top PCR and NGS-Based Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR and NGS-Based Molecular Diagnostics as of 2022)
Table 18. Ranking of Global Top PCR and NGS-Based Molecular Diagnostics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by PCR and NGS-Based Molecular Diagnostics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players PCR and NGS-Based Molecular Diagnostics Product Solution and Service
Table 22. Date of Enter into PCR and NGS-Based Molecular Diagnostics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global PCR and NGS-Based Molecular Diagnostics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Type (2018-2023)
Table 26. Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Type (2024-2033)
Table 28. Global PCR and NGS-Based Molecular Diagnostics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Application (2018-2023)
Table 30. Global PCR and NGS-Based Molecular Diagnostics Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global PCR and NGS-Based Molecular Diagnostics Revenue Market Share by Application (2024-2033)
Table 32. North America PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 33. North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 35. Europe PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe PCR and NGS-Based Molecular Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 38. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 39. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size by Region (2024-2033) & (US$ Million)
Table 41. Latin America PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 42. Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America PCR and NGS-Based Molecular Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 44. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size by Country (2024-2033) & (US$ Million)
Table 47. Thermofisher Company Detail
Table 48. Thermofisher Business Overview
Table 49. Thermofisher PCR and NGS-Based Molecular Diagnostics Product
Table 50. Thermofisher Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 51. Thermofisher Recent Development
Table 52. Illumine Company Detail
Table 53. Illumine Business Overview
Table 54. Illumine PCR and NGS-Based Molecular Diagnostics Product
Table 55. Illumine Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 56. Illumine Recent Development
Table 57. Paragon Genomics Company Detail
Table 58. Paragon Genomics Business Overview
Table 59. Paragon Genomics PCR and NGS-Based Molecular Diagnostics Product
Table 60. Paragon Genomics Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 61. Paragon Genomics Recent Development
Table 62. Roche Company Detail
Table 63. Roche Business Overview
Table 64. Roche PCR and NGS-Based Molecular Diagnostics Product
Table 65. Roche Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Qiagen Company Detail
Table 68. Qiagen Business Overview
Table 69. Qiagen PCR and NGS-Based Molecular Diagnostics Product
Table 70. Qiagen Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 71. Qiagen Recent Development
Table 72. Bioo Scientific Company Detail
Table 73. Bioo Scientific Business Overview
Table 74. Bioo Scientific PCR and NGS-Based Molecular Diagnostics Product
Table 75. Bioo Scientific Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 76. Bioo Scientific Recent Development
Table 77. Agilent Company Detail
Table 78. Agilent Business Overview
Table 79. Agilent PCR and NGS-Based Molecular Diagnostics Product
Table 80. Agilent Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 81. Agilent Recent Development
Table 82. Pillar Biosciences Company Detail
Table 83. Pillar Biosciences Business Overview
Table 84. Pillar Biosciences PCR and NGS-Based Molecular Diagnostics Product
Table 85. Pillar Biosciences Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 86. Pillar Biosciences Recent Development
Table 87. LC-Bio Technologies (Hangzhou) CO. LTD. Company Detail
Table 88. LC-Bio Technologies (Hangzhou) CO. LTD. Business Overview
Table 89. LC-Bio Technologies (Hangzhou) CO. LTD. PCR and NGS-Based Molecular Diagnostics Product
Table 90. LC-Bio Technologies (Hangzhou) CO. LTD. Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 91. LC-Bio Technologies (Hangzhou) CO. LTD. Recent Development
Table 92. iGen Technologies Company Detail
Table 93. iGen Technologies Business Overview
Table 94. iGen Technologies PCR and NGS-Based Molecular Diagnostics Product
Table 95. iGen Technologies Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 96. iGen Technologies Recent Development
Table 97. Burning Rock Company Detail
Table 98. Burning Rock Business Overview
Table 99. Burning Rock PCR and NGS-Based Molecular Diagnostics Product
Table 100. Burning Rock Revenue in PCR and NGS-Based Molecular Diagnostics Business (2018-2023) & (US$ Million)
Table 101. Burning Rock Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global PCR and NGS-Based Molecular Diagnostics Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global PCR and NGS-Based Molecular Diagnostics Market Share by Type: 2022 VS 2033
Figure 3. Biomarker Discovery Features
Figure 4. Blood Sample Testig Features
Figure 5. Others Features
Figure 6. Global PCR and NGS-Based Molecular Diagnostics Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 7. Global PCR and NGS-Based Molecular Diagnostics Market Share by Application: 2022 VS 2033
Figure 8. Hospitals Case Studies
Figure 9. Academics/Research Institutions Case Studies
Figure 10. Others Case Studies
Figure 11. PCR and NGS-Based Molecular Diagnostics Report Years Considered
Figure 12. Global PCR and NGS-Based Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global PCR and NGS-Based Molecular Diagnostics Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global PCR and NGS-Based Molecular Diagnostics Market Share by Region: 2022 VS 2033
Figure 15. Global PCR and NGS-Based Molecular Diagnostics Market Share by Players in 2022
Figure 16. Global Top PCR and NGS-Based Molecular Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PCR and NGS-Based Molecular Diagnostics as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by PCR and NGS-Based Molecular Diagnostics Revenue in 2022
Figure 18. North America PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America PCR and NGS-Based Molecular Diagnostics Market Share by Country (2018-2033)
Figure 20. United States PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe PCR and NGS-Based Molecular Diagnostics Market Share by Country (2018-2033)
Figure 24. Germany PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific PCR and NGS-Based Molecular Diagnostics Market Share by Region (2018-2033)
Figure 32. China PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America PCR and NGS-Based Molecular Diagnostics Market Share by Country (2018-2033)
Figure 40. Mexico PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa PCR and NGS-Based Molecular Diagnostics Market Share by Country (2018-2033)
Figure 44. Turkey PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia PCR and NGS-Based Molecular Diagnostics Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Thermofisher Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 47. Illumine Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 48. Paragon Genomics Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 49. Roche Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 50. Qiagen Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 51. Bioo Scientific Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 52. Agilent Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 53. Pillar Biosciences Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 54. LC-Bio Technologies (Hangzhou) CO. LTD. Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 55. iGen Technologies Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 56. Burning Rock Revenue Growth Rate in PCR and NGS-Based Molecular Diagnostics Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed